InvestorsHub Logo
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

Re: None

Wednesday, 04/30/2008 12:46:40 PM

Wednesday, April 30, 2008 12:46:40 PM

Post# of 890
Adam Fuerstein and ELN.


not sure what the "Elaniacs" as he calls them have said or done to Adam, but he has definitely stopped being objective when he covers ELN. His reporting is sometimes good. It's too bad he has chosen not to take the high road..


http://www.thestreet.com/_yahoo/newsanalysis/biotech/10414379.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA

not sure about US vs. EU and NTB vs. ADAS-COG, but frequently EU regulators ask for a different primary endpoint than FDA. THis is one of the difficult things about designing global trials. it has always been an issue IMHO.